Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Dapagliflozin(BMS5121458)
Dapagliflozin(BMS5121458)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-436 | 5mg | 193.00 | + Add to cart |
|
| R-C-436 | 10mg | 363.00 | + Add to cart |
|
| R-C-436 | 50mg | 1098.00 | + Add to cart |
|
|
|
||||
Product description
Dapagliflozin(BMS512148)is a selective,orally active inhibitor of the renal sodium-glucose co-transporter type 2(SGLT2)is in development for the treatment of type 2 diabetes mellitus.Dapagliflozin inhibits subtype 2 of SGLT2 which are responsible for at least 90% of the glucose reabsorption in the kidney.Blocking this transporter mechanism causes blood glucose to be eliminated through the urine.In clinical trials,dapagliflozin lowered HbA1c by 0.90 percentage points when added to metformin.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| CAS | 461432-26-8 |
| PDI by GPC | <1.5 |
| Solubility | Organic solvents |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---Dapagliflozin （BMS5121458） Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
